.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Novartis
US Army
Medtronic
QuintilesIMS
Daiichi Sankyo
Boehringer Ingelheim
Johnson and Johnson
Baxter
Cantor Fitzgerald

Generated: December 13, 2017

DrugPatentWatch Database Preview

Patents Expiring in May 2020

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Boehringer IngelheimATROVENT HFAipratropium bromideAEROSOL, METERED;INHALATION021527-001Nov 27, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeY
Boehringer IngelheimATROVENT HFAipratropium bromideAEROSOL, METERED;INHALATION021527-001Nov 27, 2004RXYesYes► Subscribe► Subscribe► SubscribeY
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeY
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeYY
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeA METHOD OF GENERATING AN INJECTABLE FOAM OF CONTROLLED DENSITY AND BUBBLE SIZE
TheratechnologiesEGRIFTAtesamorelin acetatePOWDER;SUBCUTANEOUS022505-001Nov 10, 2010RXYesYes► Subscribe► Subscribe► SubscribeYYREDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeYA METHOD OF GENERATING AN INJECTABLE FOAM OF CONTROLLED DENSITY AND BUBBLE SIZE
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeA METHOD OF GENERATING AN INJECTABLE FOAM OF CONTROLLED DENSITY AND BUBBLE SIZE
ProvensisVARITHENApolidocanolSOLUTION;INTRAVENOUS205098-001Nov 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeYYA METHOD OF USING A SCLEROSING AGENT FOR THE TREATMENT OF INCOMPETENT GREAT SAPHENOUS VEINS, ACCESSORY SAPHENOUS VEINS AND VISIBLE VARICOSITIES OF THE GREAT SAPHENOUS (GSV) SYSTEM ABOVE AND BELOW THE KNEE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Cerilliant
Julphar
Baxter
US Army
Deloitte
Citi
Teva
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot